Clincosm LogoSign in Get a demo

brca2 gene mutation

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

Recruiting
  • BRCA1 Gene Mutation
  • +19 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • New Brunswick, New Jersey
  • +1 more
Nov 16, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation Trial in Netherlands (Risk-reducing salpingectomy with delayed

Recruiting
  • BRCA1 Gene Mutation
  • +5 more
  • Risk-reducing salpingectomy with delayed oophorectomy
  • Risk-reducing salpingo-oophorectomy
  • Tilburg, Brabant, Netherlands
  • +13 more
Nov 1, 2022

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

Recruiting
  • BARD1 Gene Mutation
  • +14 more
  • Educational Intervention
  • +3 more
  • Houston, Texas
  • +1 more
Jun 14, 2022

BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston (Chemotherapy, Olaparib, Therapeutic

Recruiting
  • BRCA-Mutated Ovarian Carcinoma
  • +30 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer Trial in Netherlands (Salpingectomy with delayed oophorectomy,

Active, not recruiting
  • BRCA1 Gene Mutation
  • +2 more
  • Salpingectomy with delayed oophorectomy
  • Risk-reducing salpingo-oophorectomy
  • Maastricht, Limburg, Netherlands
  • +12 more
May 17, 2022

Prospective Research of Outcomes After Salpingo-oophorectomy

Active, not recruiting
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
    • San Francisco, California
      University of California, San Francisco
    Mar 21, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)

    Recruiting
    • BRCA1 Gene Mutation
    • BRCA2 Gene Mutation
    • Informational Intervention
    • Survey Administration
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Mar 2, 2022

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    Tumors, Breast, Carcinoma of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Worldwide (niraparib,

    Completed
    Has Results
    • Neoplasms, Breast
    • +5 more
    • Tucson, Arizona
    • +103 more
    Nov 2, 2021

    ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation Trial in Canada, United States (Laboratory Biomarker Analysis,

    Completed
    Has Results
    • ATM Gene Mutation
    • +20 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +1156 more
    Jun 22, 2021

    BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Petah-Tikva (DIM-Avail 100mg)

    Completed
    • BRCA1 Gene Mutation
    • BRCA2 Gene Mutation
    • DIM-Avail 100mg
    • Petah-Tikva, Israel
      Rabin Medical Center, Beilinson Hospital
    Nov 9, 2020

    Atypical Ductal Breast Hyperplasia, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (curcumin, Biomarker analysis,

    Completed
    • Atypical Ductal Breast Hyperplasia
    • +4 more
    • curcumin
    • +3 more
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Aug 29, 2019

    Pancreatic Tumors, Peutz-Jegher's Syndrome, BRCA1 Gene Mutation Trial in Little Rock (Pancreatic Cancer Screening Pathway 1,

    Withdrawn
    • Pancreatic Neoplasms
    • +7 more
    • Pancreatic Cancer Screening Pathway 1
    • Pancreatic Cancer Screening Pathway 2
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Jul 25, 2019

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Estrogen Receptor Negative Trial in Bronx, Columbus (drug, other, procedure)

    Completed
    • BRCA1 Gene Mutation
    • +11 more
    • Bronx, New York
    • +2 more
    Apr 20, 2018

    BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Petah Tikva (Endothelial function assessment, Cardiovascular biomarkers,

    Unknown status
    • BRCA1 Gene Mutation
    • BRCA2 Gene Mutation
    • Endothelial function assessment
    • +2 more
    • Petah Tikva, Israel
      Rabin Medical Center, Beilinson Hospital
    Jul 13, 2017

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Breast Cancer Trial in London, Toronto (Follow-up Telephone Genetic Counselling)

    Unknown status
    • BRCA1 Gene Mutation
    • +3 more
    • Follow-up Telephone Genetic Counselling
    • London, Ontario, Canada
    • +2 more
    Jun 7, 2016

    BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Jerusalem

    Unknown status
    • BRCA1 Gene Mutation
    • BRCA2 Gene Mutation
      • Jerusalem, Israel
        Hadassah medical center
      Jul 24, 2013